Lovenox and Cogentin drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Lovenox (enoxaparin sodium) and Cogentin (benztropine mesylate). Common drug interactions include mental status changes among females and fall among males.
The phase IV clinical study analyzes what interactions people have when they take Lovenox and Cogentin. It is created by eHealthMe based on reports of 62 people who take the same drugs from the FDA, and is updated regularly.
What is Lovenox?
Lovenox has active ingredients of enoxaparin sodium. It is often used in deep venous thrombosis. eHealthMe is studying from 48,149 Lovenox users. Check the latest studies of Lovenox.
What is Cogentin?
Cogentin has active ingredients of benztropine mesylate. It is often used in tardive dyskinesia. eHealthMe is studying from 7,692 Cogentin users. Check the latest studies of Cogentin.
62 people who take Lovenox and Cogentin together, and have interactions are studied.

What are the common drug interactions of Lovenox and Cogentin, by gender? *:
female:
- Mental status changes (general changes in brain function, such as confusion, amnesia (memory loss), loss of alertness, loss of orientation)
- Pyrexia (fever)
- Visual acuity reduced (reduced clearness of vision)
- Asthenia (weakness)
- Migraine (headache)
- Blindness transient (sudden loss of vision)
- Bone disorder
- Cardiac disorder
- Chest pain
- Ejaculation disorder
male:
- Fall
- Somnolence (a state of near-sleep, a strong desire for sleep)
- Spinal osteoarthritis (joint cartilage loss in spine)
- Acquired oesophageal web (structural abnormalities in the oesophagus)
- Amnesia (deficit in memory caused by brain damage, disease, or psychological trauma)
- Anaemia (lack of blood)
- Asthenia (weakness)
- Autonomic neuropathy (malfunction of the autonomic nervous system (ans))
- Back pain
- Bone pain
What are the common drug interactions of Lovenox and Cogentin, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
- Diabetes mellitus (diabetes, caused by a deficiency of the pancreatic hormone insulin)
- Musculoskeletal discomfort (discomfort in the body's muscles, joints, tendons, ligaments and nerves)
- Oedema peripheral (superficial swelling)
- Palpitations (feelings or sensations that your heart is pounding or racing)
- Sinus tachycardia (a heart rhythm with elevated rate of impulses originating from the sinoatrial node)
30-39:
- Ammonia increased
- Dysarthria (speech disorder)
40-49:
- Asthenia (weakness)
- Cardiac disorder
- Dizziness
- Fall
- Visual acuity reduced (reduced clearness of vision)
- Hallucination, visual (seeing things that aren't there)
- Chest pain
- Back pain
- Blindness transient (sudden loss of vision)
- Bone disorder
50-59:
- Anxiety
- Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
- Chest pain
- Febrile neutropenia (fever with reduced white blood cells)
- Injury
- Pain
- Presyncope
- Acquired oesophageal web (structural abnormalities in the oesophagus)
- Amnesia (deficit in memory caused by brain damage, disease, or psychological trauma)
- Anaemia (lack of blood)
60+:
- Fall
- Foot fracture
- Anaemia (lack of blood)
- Arteriosclerosis (thickening and hardening of arteries)
- Asthenia (weakness)
- Cardiac failure congestive
- Cataract (clouding of the lens inside the eye)
- Dehydration (dryness resulting from the removal of water)
- Dermatophytosis (inflammation of the skin and underlying muscle tissue)
- Diarrhoea
What are the existing conditions these people have? *
- Multiple Myeloma (cancer of the plasma cells): 14 people, 22.58%
- Depression: 11 people, 17.74%
- Stress And Anxiety: 10 people, 16.13%
- Constipation: 6 people, 9.68%
- Non-Hodgkin's Lymphoma (malignant (cancer) cells form in the lymph system): 6 people, 9.68%
- Headache (pain in head): 6 people, 9.68%
- High Blood Pressure: 6 people, 9.68%
- Ventricular Tachycardia (rapid heartbeat that originates in one of the lower chambers (the ventricles) of the heart): 5 people, 8.06%
- Hyperlipidaemia (presence of excess lipids in the blood): 5 people, 8.06%
- Arthritis (form of joint disorder that involves inflammation of one or more joints): 5 people, 8.06%
* Approximation only. Some reports may have incomplete information.
Do you take Lovenox and Cogentin?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
Browse all drug interactions of Lovenox and Cogentin:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Lovenox:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Cogentin:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Lovenox and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Cogentin and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study uses data from the FDA. It is based on enoxaparin sodium and benztropine mesylate (the active ingredients of Lovenox and Cogentin, respectively), and Lovenox and Cogentin (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Drug interactions of Hydrocortisone and Asparlas - 2 seconds ago
- Drug interactions of Zelboraf and Calcium - 5 seconds ago
- Could Precose cause Drowsiness? - 5 seconds ago
- Oropharyngeal Pain and drugs of ingredients of naltrexone hydrochloride - 6 seconds ago
- Rash Papular and drugs of ingredients of insulin recombinant human - 9 seconds ago
- Abscess and drugs of ingredients of vitamin k - 10 seconds ago
- Protamine Sulfate and Acute Kidney Failure for Women aged 30-39 - 11 seconds ago
- Protamine Sulfate and Renal Failure Acute for Women aged 30-39 - 11 seconds ago
- Protamine Sulfate and Renal Failure for Women aged 30-39 - 11 seconds ago
- Protamine Sulfate and Kidney Failure for Women aged 30-39 - 12 seconds ago